Skip to main content
Cofoe Medical Technology Co.,Ltd. logo

Cofoe Medical Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 301087 ISIN · CNE100004Y98 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 699 across all filing types
Latest filing 2026-04-10 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 301087

About Cofoe Medical Technology Co.,Ltd.

https://www.cofoe.com.cn

Cofoe Medical Technology Co.,Ltd. specializes in the research, development, manufacturing, and distribution of a diverse range of healthcare products. The company focuses on five primary segments: health monitoring, rehabilitation nursing, medical consumables, respiratory support, and physiotherapy. Key products include digital blood pressure monitors, infrared thermometers, wheelchairs, nursing beds, hearing aids, and oxygen concentrators. Cofoe integrates advanced manufacturing processes with a comprehensive multi-channel sales network, emphasizing smart health management and home-based medical solutions. By leveraging technological innovation and a vertically integrated supply chain, the company provides accessible equipment designed to support patient care and elderly wellness in both clinical and domestic settings.

Recent filings

Filing Released Lang Actions
公司章程（草案）（H股发行并上市后适用）
Governance Information Classification · 100% confidence The document is a detailed company charter or articles of association for 可孚医疗科技股份有限公司 (Cofoe Medical Technology Co., Ltd.), covering company organization, shareholder rights, board structure, share issuance, share transfer, and governance rules. It references regulatory frameworks such as the Company Law of China, Securities Law, Shenzhen Stock Exchange rules, and Hong Kong Listing Rules. The content is about the internal governance, shareholder meetings, board responsibilities, share capital, and related corporate governance matters. It is not a financial report, earnings release, or announcement of voting results. It is a governance document detailing the company's internal rules and structure. Therefore, the appropriate classification is Governance Information (CGR). The document length (15,000 characters) and detailed content confirm it is the actual governance document, not just an announcement or summary.
2026-04-10 Chinese
2025年年度分红派息实施公告
Notice of Dividend Amount Classification · 95% confidence The document is an announcement regarding the implementation of the 2025 annual dividend distribution by the company 可孚医疗科技股份有限公司. It details the dividend amount per share, the total dividend payout, the record date, the ex-dividend date, and the shareholders entitled to the dividend. It also references the shareholders' meeting approval of the profit distribution plan and provides instructions on dividend payment. The document is not a full annual report or financial statement but a specific announcement about dividend distribution details. This fits the definition of a Notice of Dividend Amount (DIV) filing, which announces dividend amounts, payment dates, and details for shareholders. The document length is 3128 characters, which is consistent with an announcement rather than a full report. Therefore, the correct classification is DIV with high confidence.
2026-04-02 Chinese
关于取得医疗器械注册证的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement by a company about obtaining a medical device registration certificate issued by a regulatory authority (国家药品监督管理局). It details the product name, registration certificate number, validity period, classification, and intended use. The document is short (925 characters) and serves as an official notice rather than a detailed financial or operational report. There is no financial data, management discussion, or regulatory filing related to financial performance. It is not an annual report, interim report, earnings release, or any other detailed report type. The content fits best as a Regulatory Filing (RNS) because it is a general regulatory announcement about compliance and certification, which does not fit other specific categories.
2026-03-31 Chinese
湖南启元律师事务所关于可孚医疗科技股份有限公司2025年年度股东会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the 2025 Annual General Meeting (AGM) of a company. It details the legality and validity of the AGM procedures, attendance, voting, and results. It does not contain the actual annual report or financial statements but rather confirms the proper conduct and outcomes of the AGM. The document is focused on the voting results and legal compliance of the shareholder meeting, which aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is about 4753 characters, which is sufficient for a detailed voting results announcement rather than a brief report publication announcement. Therefore, the correct classification is DVA with high confidence.
2026-03-31 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2025 Annual General Meeting (AGM) of the company, including voting results on various proposals such as the 2025 annual report, board work report, profit distribution plan, and appointment of the accounting firm. It includes meeting details, attendance, voting methods, and legal opinions on the meeting's validity. The document is not the annual report itself but an official announcement of the AGM resolutions and voting outcomes. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length is 2805 characters, which is consistent with an announcement rather than a full report.
2026-03-31 Chinese
关于香港联交所审议公司发行H股的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's application and review process for issuing H shares and listing on the Hong Kong Stock Exchange. It mentions regulatory review, approvals pending, and a caution about investment risks. The document is short (558 characters) and does not contain financial statements or detailed financial data. It is an update on capital raising and listing progress, not a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP).
2026-03-31 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.